EUVIMEDEUVIMED entdecken
Crossref

Assessing Strategies to Mitigate the Effect of Age When Using Fibrosis-4 Index to Screen for Metabolic Dysfunction–Associated Steatotic Liver Disease–Related Liver Fibrosis

Jeevan Nammi, William Southall, Ky Huynh, Elainea Smith, Sameer Al Diffalha, Kenneth Cusi, Meagan Gray, Fernando Bril

Clinical Gastroenterology and Hepatology · 2026-09

DOI: 10.1016/j.cgh.2026.09.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-09. Verfasst von Jeevan Nammi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama. Die Arbeit nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: Fibrosis-4 (FIB-4) is recommended to screen for liver fibrosis in at-risk individuals, but its performance is limited at extremes of age. This study compared different strategies to limit the effect of age on FIB-4. METHODS: Using 2 independent metabolic dysfunction-associated steatotic liver disease cohorts, we assessed FIB-4 and 4 alternative strategies to detect ≥ F2, ≥F3, and cirrhosis. The strategies assessed were: (1) standard FIB-4 with 1.3 as cutoff; (2) FIB-4, but using a cutoff of 2.0 for ≥65 years; (3) FIB-3 where age was removed from the FIB-4 formula; (4) capped FIB-4 (where 35 or 65 years were used as age inputs in individuals 65 years, respectively), and (5) log-transformed FIB-4, where the natural logarithm of age was used. Magnetic resonance elastography was used as reference in cohort #1 (n = 604), and liver biopsy in cohort #2 (n = 334). The National Health and Nutrition Examination Survey, 2017 to 2020, was used to assess the strategies in an unselected cohort. RESULTS: Among 938 participants (age, 54 ± 12 years; 50% female; body mass index, 34.7 ± 6.7 kg/m2; 42% with diabetes), 20% had ≥ F2, 13% ≥F3, and 3% cirrhosis. All strategies had similar areas under the receiver operating characteristic curve (AUROCs) for detection of ≥F2 or ≥ F3 vs magnetic resonance elastography (AUROCs, 0.76-0.78) or liver biopsy (AUROCs, 0.77-0.81). Based on prespecified or calculated cutoff points, strategies differed in sensitivity and specificity, but without major impact on positive predictive value and negative predictive value. FIB-3 demonstrated a balanced sensitivity-specificity trade-off at age extremes (

Schlagwörter

Stichwörter der Autor:innen

AgingMASHMASLDRisk StratificationScreening

Autor:innen und Institutionen

  • Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
  • Division of Internal Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
  • Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama.
  • Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama.
  • Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Florida, Gainesville, Florida.
  • Division of Gastroenterology and Hepatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.

Zitieren

APA

Nammi, J., Southall, W., Huynh, K., Smith, E., Al Diffalha, S., Cusi, K., Gray, M., & Bril, F. (2026). Assessing Strategies to Mitigate the Effect of Age When Using Fibrosis-4 Index to Screen for Metabolic Dysfunction–Associated Steatotic Liver Disease–Related Liver Fibrosis. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2026.09.003

Vancouver

Nammi J, Southall W, Huynh K, Smith E, Al Diffalha S, Cusi K, et al. Assessing Strategies to Mitigate the Effect of Age When Using Fibrosis-4 Index to Screen for Metabolic Dysfunction–Associated Steatotic Liver Disease–Related Liver Fibrosis. Clinical Gastroenterology and Hepatology. 2026. doi:10.1016/j.cgh.2026.09.003

BibTeX
@article{Nammi2026,
  author = {Nammi, Jeevan and Southall, William and Huynh, Ky and Smith, Elainea and Al Diffalha, Sameer and Cusi, Kenneth and Gray, Meagan and Bril, Fernando},
  title = {Assessing Strategies to Mitigate the Effect of Age When Using Fibrosis-4 Index to Screen for Metabolic Dysfunction–Associated Steatotic Liver Disease–Related Liver Fibrosis},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2026},
  doi = {10.1016/j.cgh.2026.09.003}
}
Kostenlos starten →